Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Other Non Operating Income (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Other Non Operating Income readings, the most recent being $2.7 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 1215.7% to $2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a N/A change, with the full-year FY2025 number at -$2.7 million, changed N/A from a year prior.
  • Other Non Operating Income hit $2.7 million in Q4 2025 for Treace Medical Concepts, up from -$612000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.0 million in Q4 2021 to a low of -$5.3 million in Q2 2022.
  • Median Other Non Operating Income over the past 5 years was -$242000.0 (2024), compared with a mean of -$377352.9.
  • The widest YoY moves for Other Non Operating Income: up 1215.7% in 2025, down 340.91% in 2025.
  • Treace Medical Concepts' Other Non Operating Income stood at $3.0 million in 2021, then plummeted by 215.5% to -$3.5 million in 2022, then skyrocketed by 59.86% to -$1.4 million in 2023, then surged by 82.71% to -$242000.0 in 2024, then surged by 1215.7% to $2.7 million in 2025.
  • The last three reported values for Other Non Operating Income were $2.7 million (Q4 2025), -$612000.0 (Q3 2025), and -$424000.0 (Q2 2025) per Business Quant data.